Table 1 Clinical and laboratory characteristics of the study group at the time of liver biopsy
Variable | Hepatic patients (N = 200) | |
|---|---|---|
Age (years) | 6.3 ± 3.8 (2–15) | |
Sex | Male | 98 (49%) |
Female | 102 (51%) | |
Weight (kg) Centiles | 18.2 ± 5.9 (9.0–40.0) (5th–75th) | |
Height (cm) Centiles | 95.4 ± 32.4 (70.0–149.0) (<3rd–85th) | |
BMI (kg/m2) Centiles | 19.3 ± 7.3 (13.0–50.7) (0.1th–95th) | |
BMI z-score | 0.13 ± 2.9 (−4.8:6.0) | |
AST (IU/L) | 142.8 ± 198.8 (20–1080) | |
ALT (IU/L) | 155.7 ± 205.8 (18–1170) | |
T. bilirubin (mg/dL) | 4.5 ± 5.03 (0.2–21.0) | |
D. bilirubin (mg/dL) | 2.6 ± 3.1 (0.1–13.0) | |
ALP (IU/L) | 520.6 ± 493 (80–1192) | |
GGT (IU/L) | 73.7 ± 119.5 (41–668) | |
Hb (g/dL) | 9.6 ± 1.7 (8.5–11.0) | |
PLTs (103/μL ) | 246.5 ± 137.9 (150.0–435.0) | |